Ashland shares target cut to $110 on lowered FY24 outlook

Wednesday, Wolfe Research adjusted its price target on shares of Ashland Inc . (NYSE:ASH), reducing it to $110 from the previous $114 while maintaining an Outperform rating. The adjustment follows a notable intra-day decline of over 10% in Ashland's share price, which analysts have attributed to several factors impacting investor sentiment.

The lowered fiscal year 2024 outlook was unexpected, as market expectations had been for a "sleepy" performance release. Additionally, concerns have grown regarding Ashland's ability to consistently outperform market expectations, given the current uncertain macroeconomic environment. Analysts have also noted a higher degree of uncertainty in the Life Sciences (LS) sector, which is a critical component of the bullish case for Ashland.

Furthermore, Ashland's ongoing asset sales and portfolio rationalizations have introduced additional variables into the company's financial narrative. While it is believed that Ashland's transformation into a premier supplier for the Pharma, Personal Care, and Coatings industries is approximately 95% complete, with Avoca representing the final 5%, there is a sense of impatience among investors for definitive numbers.

Despite some frustration over a perceived mid-year "false start," Wolfe Research defends the stock. Ashland's strategic portfolio, new product introduction (NPI) optionality, and strong balance sheet are seen as factors that skew the risk/reward ratio favorably. However, analysts have indicated that the stock may remain range-bound for the time being. At its current price in the low $80 range, Ashland is nearing an approximately 8% free cash flow yield on the fiscal year 2025 projections, which is considered an attractively historical entry point for investors.

In other recent news, Ashland Inc. has been the subject of several major developments. Argus maintained a Buy rating on the company and increased the stock's price target to $118 from $109, due to a gradual increase in demand across most of Ashland's end markets. In addition, BMO Capital Markets raised Ashland's price target to $105 from $97, acknowledging the company's successful alignment of production with customer demand.

Ashland also announced a five percent increase in its quarterly cash dividend, set at $0.405 per share, reflecting the company's financial health and its ability to generate sufficient cash flow. Furthermore, Ashland expanded its board with the appointment of Ashish K. Kulkarni, CEO of Kebotix, as part of preparation for potential director retirements, underlining a strategy to adapt and grow its portfolio.

Lastly, Ashland has entered into a definitive agreement to divest its nutraceuticals business to private equity firm Turnspire Capital Partners LLC, as part of the company's strategy to focus on its core portfolio. These are recent developments, and investors are advised to monitor Ashland's progress closely as it navigates these changes.

InvestingPro Insights

As Wolfe Research adjusts its price target on Ashland Inc. (NYSE:ASH), it is vital for investors to consider key financial metrics and insights that could influence their investment decisions. According to InvestingPro data, Ashland boasts a market capitalization of approximately $4.14 billion and a price-to-earnings (P/E) ratio of 28.2. Notably, the adjusted P/E ratio for the last twelve months as of Q3 2024 stands at a lower 17.59, suggesting a more favorable valuation in recent times. The company's revenue for the same period was reported at $2.108 billion, despite a revenue decline of 8.59%.

InvestingPro Tips highlight several positive aspects of Ashland's financial health and shareholder value. The company's management has been actively engaged in share buybacks, signaling confidence in the company's value. Furthermore, Ashland has a track record of raising its dividend for five consecutive years, with a current dividend yield of 1.79%. This consistent performance is underlined by the fact that Ashland has maintained dividend payments for an impressive 54 consecutive years.

Investors may also find solace in the fact that Ashland's liquid assets exceed its short-term obligations, providing financial stability. Additionally, analysts predict profitability for the current year, with the company having been profitable over the last twelve months. For those interested in further insights, InvestingPro offers additional tips on Ashland, which can be found by visiting their website.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.